GlassScriptPhysician profile
Rodrigo Diaz
NPI 1659330900
$1,969.66
in general payments reported to CMS, 2019-2025
10 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $45.44 · 2021: $153 · 2022: $424 · 2023: $228 · 2024: $317 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $684.43 | 2019-2025 | Cobas 4800 Ct/Ng Test V2.0 |
| Abbvie INC. | $488.00 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $326.09 | 2019-2023 | Gardasil 9 |
| Hologic Sales and Service, LLC | $195.97 | 2021-2023 | Thinprep 2000 Processor |
| Janssen Pharmaceuticals, INC | $100.00 | 2022 | |
| Gen-Probe Sales & Service, INC. | $90.20 | 2022 | |
| Pbg Puerto Rico LLC | $35.00 | 2021 | |
| Organon LLC | $23.08 | 2024 | |
| Smith+Nephew, INC. | $13.85 | 2020 | |
| Medtronic, INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodrigo Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.